Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Post-traumatic stress disorder in adult victims of cluster munitions in Lebanon: a 10-year longitudinal study.

Fares J, Gebeily S, Saad M, Harati H, Nabha S, Said N, Kanso M, Abdel Rassoul R, Fares Y.

BMJ Open. 2017 Aug 18;7(8):e017214. doi: 10.1136/bmjopen-2017-017214.

2.

C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis.

Wiesner C, Nabha SM, Dos Santos EB, Yamamoto H, Meng H, Melchior SW, Bittinger F, Thüroff JW, Vessella RL, Cher ML, Bonfil RD.

Neoplasia. 2008 Sep;10(9):996-1003.

3.

Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.

Dong Z, Saliganan AD, Meng H, Nabha SM, Sabbota AL, Sheng S, Bonfil RD, Cher ML.

Neoplasia. 2008 May;10(5):439-49.

4.

Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner.

Nabha SM, dos Santos EB, Yamamoto HA, Belizi A, Dong Z, Meng H, Saliganan A, Sabbota A, Bonfil RD, Cher ML.

Int J Cancer. 2008 Jun 1;122(11):2482-90. doi: 10.1002/ijc.23431.

5.

Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell line.

Gurzov EN, Nabha SM, Yamamoto H, Meng H, Scharovsky OG, Bonfil RD.

BMC Cancer. 2007 Oct 1;7:184.

6.

Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.

Bonfil RD, Dong Z, Trindade Filho JC, Sabbota A, Osenkowski P, Nabha S, Yamamoto H, Chinni SR, Zhao H, Mobashery S, Vessella RL, Fridman R, Cher ML.

Am J Pathol. 2007 Jun;170(6):2100-11.

7.

Heterogeneous activation of MMP-9 due to prostate cancer-bone interaction.

Wiesner C, Bonfil RD, Dong Z, Yamamoto H, Nabha SM, Meng H, Saliganan A, Sabbota A, Cher ML.

Urology. 2007 Apr;69(4):795-9.

PMID:
17445684
8.

Somatic embryogenesis and rhizogenesis of tissue cultures of two genotypes of Papaver somniferum: relationships to alkaloids production.

Laurain-Mattar D, Gillet-Manceau F, Buchon L, Nabha S, Fliniaux MA, Jacquin-Bubreuil A.

Planta Med. 1999 Mar;65(2):167-70.

PMID:
17260250
9.

Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.

Nabha SM, Bonfil RD, Yamamoto HA, Belizi A, Wiesner C, Dong Z, Cher ML.

Clin Exp Metastasis. 2006;23(7-8):335-44. Epub 2006 Nov 30.

PMID:
17136575
10.

Quantitative assessment of small intraosseous prostate cancer burden in SCID mice using fluorescence imaging.

Yamamoto H, Bonfil RD, Wiesner C, Nabha S, Dong Z, Meng H, Saliganan A, Sabbota A, Chinni SR, Cher ML.

Prostate. 2007 Jan 1;67(1):107-14.

PMID:
17075820
11.

Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor.

Bonfil RD, Sabbota A, Nabha S, Bernardo MM, Dong Z, Meng H, Yamamoto H, Chinni SR, Lim IT, Chang M, Filetti LC, Mobashery S, Cher ML, Fridman R.

Int J Cancer. 2006 Jun 1;118(11):2721-6.

12.

Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells.

Nabha SM, Glaros S, Hong M, Lykkesfeldt AE, Schiff R, Osborne K, Reddy KB.

Oncogene. 2005 Apr 28;24(19):3166-76.

PMID:
15735693
13.

Role of MAP kinase in tumor progression and invasion.

Reddy KB, Nabha SM, Atanaskova N.

Cancer Metastasis Rev. 2003 Dec;22(4):395-403. Review.

PMID:
12884914
14.
15.

Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.

Nabha SM, Mohammad RM, Dandashi MH, Coupaye-Gerard B, Aboukameel A, Pettit GR, Al-Katib AM.

Clin Cancer Res. 2002 Aug;8(8):2735-41.

16.

Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacy.

Nabha SM, Mohammad RM, Wall NR, Dutcher JA, Salkini BM, Pettit GR, Al-Katib AM.

Anticancer Drugs. 2001 Jan;12(1):57-63.

PMID:
11272287
17.

Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines.

Nabha SM, Wall NR, Mohammad RM, Pettit GR, Al-Katib AM.

Anticancer Drugs. 2000 Jun;11(5):385-92.

PMID:
10912955
18.
19.

Chronic inguinal hernia.

Levine BJ, Nabha S, Bouzoukis JK.

J Emerg Med. 1999 May-Jun;17(3):515-6. No abstract available.

PMID:
10338249

Supplemental Content

Support Center